AstraZeneca ’s Phase III trial shows benralizumab minimises OCS use in asthma patients

AstraZeneca has reported positive results from its Phase III clinical trial of benralizumab in combination with standard-of-care treatment for patients with severe asthma.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news